MoneyWorks4Me

Balaxi Pharma. - Quaterly Results

02 Aug 2022 Evaluate
A decrease in the sales to Rs. 264.54 millions was observed for the quarter ended June 2022. The sales stood at Rs. 291.80 millions during the similar quarter previous year.Net profit stood at Rs. 53.35  millions  compared to Rs. 44.33 millions in the corresponding previous quarter,high by 20.35%.OP of the company witnessed a marginal growth to 68.08 millions from 59.63 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 264.54 291.80 -9.34 264.54 291.80 -9.34 1012.92 868.71 16.60
Other Income 25.72 9.92 159.27 25.72 9.92 159.27 27.48 18.10 51.82
PBIDT 68.08 59.63 14.17 68.08 59.63 14.17 200.10 206.98 -3.32
Interest 1.96 0.03 6433.33 1.96 0.03 6433.33 0.61 0.13 369.23
PBDT 66.12 59.60 10.94 66.12 59.60 10.94 199.49 206.85 -3.56
Depreciation 0.80 0.26 207.69 0.80 0.26 207.69 2.50 0.88 184.09
PBT 65.32 59.34 10.08 65.32 59.34 10.08 196.99 205.97 -4.36
TAX 11.97 15.01 -20.25 11.97 15.01 -20.25 50.32 54.64 -7.91
Deferred Tax -0.04 -0.01 300.00 -0.04 -0.01 300.00 0.32 0.04 700.00
PAT 53.35 44.33 20.35 53.35 44.33 20.35 146.67 151.33 -3.08
Equity 100.00 100.00 0.00 100.00 100.00 0.00 100.00 100.00 0.00
PBIDTM(%) 25.74 20.44 25.94 25.74 20.44 25.94 19.75 23.83 -17.09
Peers